Integrated Care Pathways and Workplace Testing
September 11, 2024 | 12:00 – 1:00 pm ET
Image For Activity Cover
Availability
On-Demand
2 Courses
Expires on 10/12/2024
Cost
ACMG Member: $40.00
Non-Member: $60.00
Postdoc/Trainee (M): $15.00
Postdoc/Trainee (NM): $25.00
Student (M): $0.00
Student (NM): $10.00
Credit Offered
2 CME (AMA) Credits
2 CME (Other) Credits
2 P.A.C.E. Credits
2 NSGC Credits

Join us for Part Two of our captivating webinar series: "Advancements in Genomic Medicine: Navigating Health and Equity." 

 

📅 September 11, 2024

 12 pm – 2:00 pm ET

 Earn Educational Credits for attending!

 

🌐 How to Register:

  1. Click the "Content" tab, and select the webinar you want to attend.
  2. Check your email, including your spam folder, for a confirmation message containing the access details for the webinar.

Promise and Perils of Voluntary Workplace Genetic Testing

September 11, 2024 | 12:00 – 1:00 pm ET

 

Description:

Many employers in the US are offering access to health-related genetic testing as a benefit to employees through workplace wellness programs. Voluntary workplace genetic testing (wGT) can inform employees on risks for common complex conditions (e.g., cardiovascular disease) as well as Mendelian disorders (e.g., hereditary breast and ovarian cancer syndrome). wGT has the potential to increase access to health risk assessments to broad segments of the employed population, but its ethical, legal, and social implications (ELSI) are not fully defined, and wide-spread adoption of wGT could have important consequences for the medical genetic community. This session will engage attendees in an exploration of wGT informed by perspectives of three key stakeholders (employers; employees; and genetic counselors) on knowledge and understanding, perceived benefits and concerns, and ELSI considerations developed through a 4-year NHGRI funded multisite mixed-methods R01 study (R01 HG010679). The session will emphasize the potential implications wGT has for employees, genetics providers, health systems, and potential policy issues for wGT.

 

Target Audience

All healthcare professionals interested in the diagnosis, management, treatment, and prevention of genetic conditions and increasing their understanding of the genetic basis of common, chronic health problems affecting both children and adults will find the programming applicable to their practice. The ACMG Annual Meeting is targeted for the following professionals:

 

  • Medical and clinical geneticists; genetic counselors; pediatric, obstetric, and maternal-fetal specialists; and all medical practitioners who are providing comprehensive diagnostic, management, and counseling services for patients with, or at risk for, genetically influenced health problems.
  • Laboratory directors and technicians who conduct genetic testing.
  • Researchers involved in the discovery of genetic disorders and treatments.
  • Clinical, laboratory and research trainees of genetics and all biomedical sciences.
  • Any healthcare and public health professionals who have an interest in medical and clinical genetics and genomics.
  • Advocates for patients with genetic conditions and their families.

 

Agenda

Presentations followed by live Q&A. 

Presentation

Presenter

Affiliation

Welcome and Introduction

Kunal Sanghavi, MBBS, MS

The Jackson Laboratory

Overview of Workplace Genetic Testing in the United States

Elizabeth Charnysh, MS

The Jackson Laboratory

Employer Perspectives on Workplace Genetic Testing

Debra JH Mathews, PhD, MA

Johns Hopkins University School of Medicine

Employees Perspectives on Workplace Genetic Testing

Scott Roberts, PhD

University of Michigan

Genetic Counselor Perspective on Workplace Genetic Testing

Wendy R. Uhlmann, MS, LCGC

University of Michigan

 

Learning Objectives

At the conclusion of this session, participants should be able to:

  1. Outline the prevalence and nature of workplace genomic testing in the United States.
  2. Describe findings from survey research examining employees' views and experiences of workplace genetic testing.
  3. Illustrate genetic counselors’ experiences and perspectives on workplace genetic testing.
  4. Identify key social, ethical, and legal issues of workplace genetic testing across key stakeholder groups.

Meet the Faculty:

Elizabeth Charnysh, MS, The Jackson Laboratory for Genomic Medicine

Kuntal Sanghavi, MBBS, MS, CGC, The Jackson Laboratory for Genomic Medicine

Debra Mathews, PhD, MA, Johns Hopkins University

Scott Roberts, PhD, University of Michigan School of Public

Wendy Uhlmann, MS, LCGC, University of Michigan School of Medicine

Transitions and Health Care of Adults with Genetic Syndromes

September 11, 2024 | 1:00 – 2:00 pm ET

 

 

Description:

In this session, our presenters will provide perspectives on healthcare of adults with common genetic syndromes (Down syndrome, RASopathies / Costello syndrome, and 22q11 deletion syndrome). 

 

With many clinical geneticists based at pediatric hospitals, transition of subspecialty and even primary care for adult patients with multisystemic needs presents an almost universal challenge for healthcare providers and families alike. Families of children with medical complexity related to rare syndromes often form close bonds with their pediatric providers, making “aging out” of pediatric care and finding a new team a daunting task. Having an improved understanding of adult-specific issues and outcomes can improve care for adults and pediatric patients alike–-families of newly diagnosed patients often desire to know as much as possible about what to expect, including into adulthood. 

 

This information is valuable to practicing geneticists because:

 

  • Current capacity of existing multidisciplinary clinics can only accommodate medical care of 5% of the adults with Down syndrome in the United States. Medical geneticists with knowledge of genetic syndromes can work to fill this gap (Santoro et al. 2021).
  • Adult healthcare guidelines exist (Tsou et al. 2020); adherence to general population management guidelines for adults with Down syndrome (Jensen et al. 2021) and to AAP guidelines (Santoro et al. 2023) is low.
  • Multidisciplinary team approach improves care of those with 22q11.2 deletion syndrome (Hickey et al. 2020).
  • Using some key syndromes as example cases, our proposal will focus on two aspects of care of adults with genetic syndromes. 

First, we will review key aspects of transition planning for individuals with genetic syndromes. Transition is a broad topic including aspects of guardianship, graduation from high school to adult service organizations, and has implications on availability of appropriately-trained medical specialists. The transition time frame has gained increased awareness and there are best practices on steps to include and increasing resources. Transition to adulthood is a multifaceted process that requires integration of numerous domains within a young person's life, including their health care. For children with special health care needs, the transition process can be markedly more difficult to navigate. This is especially true for children with Down syndrome (DS) who receive fewer transition planning services. Survey of parents of individuals with Down syndrome identified that 5% or less reported completing one of the core transition outcomes: transition readiness assessment, portable medical summary, or written transition plan (VanZant and McCormick 2021). One of our speakers is a Med-Peds trained internist specializing in Transition care.

 

Additionally, we will focus on aspects of healthcare maintenance for three specific genetic syndromes. We have chosen these syndromes because they are relatively common conditions, which are likely to be experienced by practicing clinical geneticists and genetic counselors. These three syndromes also demonstrate genetic conditions with both congenital conditions in childhood, and adult-onset conditions that may develop later in life and are important for clinicians to be aware of. Our team includes geneticists at specialty clinics in three different locations, with varied clinic models and approaches. Speakers can also share practical advice on how to build a medical home for adults with genetic syndromes.

 

Target Audience

All healthcare professionals interested in the diagnosis, management, treatment, and prevention of genetic conditions and increasing their understanding of the genetic basis of common, chronic health problems affecting both children and adults will find the programming applicable to their practice. The ACMG Annual Meeting is targeted for the following professionals:

 

  • Medical and clinical geneticists; genetic counselors; pediatric, obstetric, and maternal-fetal specialists; and all medical practitioners who are providing comprehensive diagnostic, management, and counseling services for patients with, or at risk for, genetically influenced health problems.
  • Laboratory directors and technicians who conduct genetic testing.
  • Researchers involved in the discovery of genetic disorders and treatments.
  • Clinical, laboratory and research trainees of genetics and all biomedical sciences.
  • Any healthcare and public health professionals who have an interest in medical and clinical genetics and genomics.
  • Advocates for patients with genetic conditions and their families.

 

Agenda

Presentations followed by live Q&A. 

Presentation

Presenter

Affiliation

Welcome and Introduction

Nicole Weaver, MD

Cincinnati Children's Hospital Medical Center

Adolescents, Adults, and Aging in Down syndrome

Stephanie Santoro, MD

Massachusetts General Hospital

Best Practices in Supporting a 'Healthy' Transition from Pediatric to Adult Medical Homes

Andrew McCormick, MD

University of  Pittsburgh School of Medicine

22q11.2 Deletion Syndrome: Management from Transition and Across the Lifespan

Anne Bassett, CM, MD, FRCPC

The Dalglish Family 22q Clinic for Adults

RASopathies Grown up: Considerations for Health care of Adults

Nicole Weaver, MD

Cincinnati Children's Hospital Medical Center


Learning Objectives

At the conclusion of this session, participants should be able to:

  1. Discuss the management of adults with 22q11.2 microdeletion from transition and across the lifespan.
  2. Discuss management of adults with RASopathies (e.g. Costello), gaps in knowledge of best practices for care of adults.
  3. Review existing health supervision guidelines for adults with Down syndrome and unique aspects of care (e.g. dementia).
  4. Explain the key aspects of the transition period, resources from the general population, especially genetic syndromes.

 

Meet the Faculty

 

Andrew McCormick, MD, UPMC Children’s Hospital of Pittsburgh

Anne Bassett, MD, Toronto General Hospital

Nicole Weaver, MD, Cincinnati Children's Medical Center

Stephanie Santoro, MD, Massachusetts General Hospital

© 2024 American College of Medical Genetics and Genomics. All rights reserved.

Powered By